近十年间肝细胞癌诊断指南的变化。

Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period.

机构信息

Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.

出版信息

Clin Mol Hepatol. 2012 Sep;18(3):258-67. doi: 10.3350/cmh.2012.18.3.258. Epub 2012 Sep 25.

Abstract

Hepatocellular carcinoma (HCC) is the third most common cause of cancer deaths in the world. There have been many advances in the diagnosis of HCC during the last ten years, especially in the imaging techniques. The Korean Liver cancer study group (KLCSG), European Association for the Study of the Liver (EASL), American Association for the Study of Liver disease (AASLD), and Asian-Pacific Association for the Study of Liver (APASL) have made and changed the HCC guidelines with the advances in the imaging techniques and according to the results of the researches on HCC. We reviewed the changes of the imaging guidelines in HCC diagnosis according to the advances in the imaging techniques. Further studies will be necessary to resolve the controversies in the diagnosis of HCC smaller than 1 cm in size.

摘要

肝细胞癌 (HCC) 是全球癌症死亡的第三大常见原因。在过去十年中,HCC 的诊断取得了许多进展,特别是在影像学技术方面。韩国肝癌研究组 (KLCSG)、欧洲肝脏研究协会 (EASL)、美国肝病研究协会 (AASLD) 和亚太肝脏研究协会 (APASL) 根据影像学技术的进步和 HCC 研究的结果制定和修改了 HCC 指南。我们根据影像学技术的进步,回顾了 HCC 诊断影像学指南的变化。进一步的研究将有助于解决直径小于 1 厘米的 HCC 诊断中的争议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索